Assessment of the immunogenicity and safety of the Northern Hemisphere 2009/2010-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations.

Trial Profile

Assessment of the immunogenicity and safety of the Northern Hemisphere 2009/2010-season influenza vaccine in elderly and young subjects according to European Medicines Agency (EMEA) regulations.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2012

At a glance

  • Drugs Influenza virus vaccine liposomal (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors Crucell
  • Most Recent Events

    • 28 Feb 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT01306253).
    • 31 Aug 2009 Last checked against ISRCTN: Current Controlled Trials.
    • 31 Aug 2009 Status changed from unconfirmed to completed as reported by ISRCTN: Current Controlled Trials.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top